Yüklüyor......

Ustekinumab in Crohn’s disease: evidence to date and place in therapy

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) with uncertain etiology. Biologic agents have revolutionized the treatment of CD but nonresponders remain a challenge. Ustekinumab is an interleukin 12/23p40 inhibitor that was recently found effective in treating CD. We reviewed the curren...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Chronic Dis
Asıl Yazarlar: Engel, Tal, Kopylov, Uri
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935835/
https://ncbi.nlm.nih.gov/pubmed/27433311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316653306
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!